Acute kidney injury in patients receiving high-dose etoposide phosphate as conditioning prior to hematopoietic stem cell transplantation in hematologic malignancies …
T Stewart, M Dowling, B Janson, J Siderov… - Leukemia & …, 2023 - Taylor & Francis
High-dose etoposide phosphate (HDEP) is commonly used in combination with total body
irradiation (TBI) prior to allogeneic stem cell transplantation (AlloSCT)[1] and with …
irradiation (TBI) prior to allogeneic stem cell transplantation (AlloSCT)[1] and with …
Unexpected acute renal injury after high‐dose etoposide phosphate and total body irradiation in children undergoing hematopoietic stem cell transplantation
C Cordero, C Loboda, I Clerc‐Urmès… - Pediatric Blood & …, 2017 - Wiley Online Library
High‐dose etoposide phosphate, a water‐soluble prodrug of etoposide, may be used after
total body irradiation (TBI) in pediatric allogeneic bone marrow transplantation for …
total body irradiation (TBI) in pediatric allogeneic bone marrow transplantation for …
Acute kidney injury after high dose etoposide phosphate: a retrospective study in children receiving an allogeneic hematopoetic stem cell transplantation
D Barnoud, C Pinçon, B Bruno, J Bene… - Pediatric Blood & …, 2018 - Wiley Online Library
Background Etoposide phosphate (EP; single injection, 60 mg/kg) followed by total body
irradiation (TBI) at 12 Gy has been used as an allogeneic stem cell transplantation (allo …
irradiation (TBI) at 12 Gy has been used as an allogeneic stem cell transplantation (allo …
Comparative pharmacokinetic study of high-dose etoposide and etoposide phosphate in patients with lymphoid malignancy receiving autologous stem cell …
RT Dorr, A Briggs, P Kintzel, R Meyers… - Bone marrow …, 2003 - nature.com
The pharmacokinetics of two etoposide (E) formulations were evaluated in patients with
refractory hematologic malignancies receiving high-dose conditioning with autologous stem …
refractory hematologic malignancies receiving high-dose conditioning with autologous stem …
A phase I study of etoposide phosphate administered as a daily 30‐minute infusion for 5 days
DS Thompson, FA Greco, AA Miller… - Clinical …, 1995 - Wiley Online Library
Purpose To determine the maximum tolerated dose, toxicities, kinetics, and disposition of
etoposide phosphate when administered as a daily 30‐minute infusion for 5 days. Patients …
etoposide phosphate when administered as a daily 30‐minute infusion for 5 days. Patients …
Pharmacokinetic evaluation of high-dose etoposide phosphate after a 2-hour infusion in patients with solid tumors
W Kreis, DR Budman, V Vinciguerra, K Hock… - Cancer chemotherapy …, 1996 - Springer
Etoposide phosphate, a water soluble prodrug of etoposide, was evaluated at levels
potentially useful in transplantation settings in patients with malignancies. For …
potentially useful in transplantation settings in patients with malignancies. For …
Phase I study of high-dose etoposide phosphate in man.
SZ Fields, DR Budman, RR Young, W Kreis… - Bone marrow …, 1996 - europepmc.org
Etoposide is a widely used cytotoxic agent with a broad spectrum of activity in human
malignancies. This agent has been incorporated into many transplant regimens although …
malignancies. This agent has been incorporated into many transplant regimens although …
Phase I and pharmacokinetic study of etoposide phosphate by protracted venous infusion in patients with advanced cancer.
N Soni, NJ Meropol, L Pendyala, D Noel… - Journal of clinical …, 1997 - ascopubs.org
PURPOSE Etoposide has schedule-dependent cytotoxic activity, and clinical resistance may
be overcome with prolonged low-dose therapy. Oral bioavailability is variable, and …
be overcome with prolonged low-dose therapy. Oral bioavailability is variable, and …
Etoposide phosphate: what, why, where, and how?
L Schacter - Seminars in oncology, 1996 - europepmc.org
The podophyllotoxin derivatives etoposide and teniposide are active in the treatment of a
variety of malignant conditions. Both represent chemical modifications of podophyllin, an …
variety of malignant conditions. Both represent chemical modifications of podophyllin, an …
When is autologous bone marrow transplantation safe after high‐dose treatment with etoposide?
TJ Littlewood, BP Spragg… - Clinical & Laboratory …, 1985 - Wiley Online Library
Summary Etoposide (VP16–213) is widely used in the treatment of malignant disease and
increasingly high doses are now used in conjunction with autologous bone marrow …
increasingly high doses are now used in conjunction with autologous bone marrow …